InvestorsHub Logo

horselover45

09/22/14 6:05 PM

#191347 RE: cheynew #191346

I guess that we are looking at different big pictures.

My big picture tells me that we will get good news on liver trial,some of the preclinical collaborations and that Sunrise will succeed in Phase 111 lung trial.

This pattern of knock it down a few cents every day will stop one of these days if we are right about the science and believe Phil Thorpe's creation will be worth consideration for a Nobel.

That is what this investor believes.

Andy C.
Not that it matters to most people but I will be at Annual Meeting and hope to get at least a couple of my questions answered.

Now my pet peeve.
People that claim to be involved in Peregrine for many years and live close should go and ask questions. Otherwise their dedication at least in my mind is questionable.

eastcoastguy

09/22/14 9:16 PM

#191355 RE: cheynew #191346

Interesting that we closed the first day of trading 2014 at 1.39 and closed today at the same. Looking at the Russell 2k it's understandable why small biopharmaceuticals like PPHM are down. The Russell is off 2.6% YTD. The optimist in me says we're doing better than that.

Looking at both charts you'll see the spike in the Russell in Feb/March. Similar charts with many bio's. Same thing happened Friday with many small caps spiking at the close. I suspect it was short Russell positions closing out options forcing buys in the index stocks.

PPHM will get buffeted by bigger market issues until there is trial news. I suspect we'll get something to chew on before the ASM from the IST's. With favorable data we'll hopefully counter any market turbulence.